Abstract
In order to increase the dose of antineoplastic agents in the tumor area, the concept of magnetic drug targeting (MDT) has been developed. Magnetic nanoparticles consisting of iron oxide and a biocompatible cover layer suspended in an aqueous solution (ferrofluid) serve as carriers for chemotherapeutics being enriched by an external magnetic field after intra-arterial application in desired body compartments (i.e., tumor). We established an ex vivo model to simulate in vivo conditions in a circulating system consisting of magnetic iron oxide nanoparticles passing an intact bovine artery and being focused by an external magnetic field to study their distribution in the vessel. Micro-computed X-ray tomography (XμCT) and histology can elucidate the arrangement of these particles after application. XμCT-analysis has been performed on arterial sections after MDT in order to determine the distribution of the nanoparticles. These measurements have been carried out with a cone X-ray source and corresponding histological sections were stained with Prussian blue. It could be shown that combining XμCT and histology offers the opportunity for a better understanding of the mechanisms of nanoparticle deposition in the vascular system after MDT.
Similar content being viewed by others
Abbreviations
- MDT:
-
Magnetic drug targeting
- DLS:
-
Dynamic light scattering
- XμCT:
-
Micro-computed tomography
References
Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lubbe AS (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60:6641–6648
Alexiou C, Jurgons R, Schmid RJ, Bergemann C, Henke J, Erhardt W, Huenges E, Parak F (2003) Magnetic drug targeting—biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 11:139–149
Alexiou C, Diehl D, Henninger P, Iro H, Rockelein R, Schmidt W, Weber H (2006a) A high field gradient magnet for magnetic drug targeting. IEEE Trans Appl Supercond 16:1527–1530
Alexiou C, Schmid RJ, Jurgons R, Kremer M, Wanner G, Bergemann C, Huenges E, Nawroth T, Arnold W, Parak FG (2006b) Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J Biophys Lett 35:446–450
Asmatulu R, Zalich MA, Claus RO, Riffle JS (2005) Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. J Magn Magn Mater 292:108–119
Brunke O, Odenbach S, Jurgons R, Alexiou C, Hilger I, Beckmann F (2006) Determination of the magnetic particle distribution in tumour tissue by means of X-ray tomography. J Phys Condens Matter 18:S2903–S2917
Collins JM (1984) Pharmacological rationale for regional drug delivery. J Clin Oncol 2:498–505
Häfeli U (2001) Magneto-and radio-pharmaceuticals, radioactive magnetic microspheres. In: Arshady R, Guyot A (eds) Microspheres microcapsules and liposomes. Citus, London, pp 559–584
Khalafalla SE, Reimers GW (1980) Preparation of dilution-stable aqueous magnetic fluids. IEEE Trans Magn 16:178–183
Neuberger T, Schopf B, Hofmann H, Hofmann M, von Rechenberg B (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293:483–496
Rahn H, Gomez-Morilla I, Jurgons R, Alexiou C, Odenbach S (2008) Microcomputed tomography analysis of ferrofluids used for cancer treatment. J Phys Condens Matter 20:204152–204156
Seliger C, Jurgons R, Wiekhorst F, Eberbeck D, Trahms L, Iro H, Alexiou C (2007) In vitro investigation of the behaviour of magnetic particles by a circulating artery model. J Magn Magn Mater 311:358–362
Storm G, Belliot SO, Daemen T, Lasic DD (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliver Rev 17:31–48
Taupitz M, Wagner S, Hamm B, Dienemann D, Lawaczeck R, Wolf KJ (1993) MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumour model. Acta Radiol 34:10–15
Torchilin VP (2000) Drug targeting. Eur J Pharm Sci 11:S81–S91
Acknowledgments
These studies were supported by Else Kröner-Fresenius-Foundation, Bad Homburg v.d.H., Germany and Deutsche Forschungsgemeinschaft (DFG-AL 552/3-1 and DFG-OD 18/16-1), Germany.
Author information
Authors and Affiliations
Corresponding author
Additional information
R. Tietze and H. Rahn contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tietze, R., Rahn, H., Lyer, S. et al. Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology. Histochem Cell Biol 135, 153–158 (2011). https://doi.org/10.1007/s00418-011-0780-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-011-0780-8